Cargando…

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study

We investigated the prevalence and clinical metabolic characteristics of lean nonalcoholic fatty liver disease (NAFLD) in an elderly Chinese population and assessed the relevance of lipid markers and genetic variation. All 5,338 community subjects underwent detailed clinical and laboratory examinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jie, Wu, Na, Yang, Yukun, Zhai, Xiangyu, Yuan, Fan, Zhang, Fengwei, Yu, Ning, Li, Dong, Wang, Ruirui, Wang, Jianying, Zhang, Lei, Shi, Yi, He, Guang, Liu, Baocheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830772/ https://www.ncbi.nlm.nih.gov/pubmed/36627697 http://dx.doi.org/10.1186/s12902-022-01234-w

Ejemplares similares

Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease
por: Wu, Na, et al.
Publicado: (2022)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD
por: Wu, Na, et al.
Publicado: (2023)

Genetic variation in TBC1 domain family member 1 gene associates with the risk of lean NAFLD via high-density lipoprotein
por: Wu, Na, et al.
Publicado: (2023)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

The gender-specific bidirectional relations between chronic diseases and total bilirubin/urea in the elderly population: A 3-year longitudinal study
por: Wu, Na, et al.
Publicado: (2022)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023)

Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
por: Zhang, Fengwei, et al.
Publicado: (2022)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

A bibliometric analysis of autophagy in atherosclerosis from 2012 to 2021
por: Zhang, Fengwei, et al.
Publicado: (2022)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China
por: Lan, Yanqi, et al.
Publicado: (2022)

Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup
por: Hsu, Chiao-Lin, et al.
Publicado: (2019)

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease
por: Shen, Nan, et al.
Publicado: (2023)

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus
por: Zhang, Xingxing, et al.
Publicado: (2022)

Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
por: Yun, Yeojun, et al.
Publicado: (2019)

Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
por: Liu, Lu, et al.
Publicado: (2022)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Fei, Na, et al.
Publicado: (2020)

Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
por: Li, Hui, et al.
Publicado: (2019)

Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
por: Young, Steven, et al.
Publicado: (2020)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
por: Iino, Chikara, et al.
Publicado: (2022)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Nonalcoholic fatty pancreas disease: An emerging clinical challenge
por: Zhang, Cheng-Lei, et al.
Publicado: (2021)

Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study
por: Wang, Wenting, et al.
Publicado: (2022)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
por: Iritani, Soichi, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center
por: Alsuhaibani, Khalid A., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
por: Cho, Yoosun, et al.
Publicado: (2022)

Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia
por: Khayyat, Yasir Mohammed
Publicado: (2021)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals
por: Sun, Zewen, et al.
Publicado: (2023)

Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine
por: Sun, Jijia, et al.
Publicado: (2022)

Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020
por: Kalligeros, Markos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h72ievvf6jfiasrk3d2lu0utls